4//SEC Filing
BIOGEN IDEC INC. 4
Accession 0001127602-15-006494
$BIIBCIK 0000875045operating
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 8:26 PM ET
Size
16.5 KB
Accession
0001127602-15-006494
Insider Transaction Report
Form 4
BIOGEN IDEC INC.BIIB
Kingsley Stuart A
EVP, Global Comm. Operations
Transactions
- Tax Payment
Common Stock
2015-02-12$392.11/sh−1,058$414,852→ 7,416 total - Exercise/Conversion
Common Stock
2015-02-12+1,355→ 8,771 total - Tax Payment
Common Stock
2015-02-12$392.11/sh−639$250,558→ 8,132 total - Exercise/Conversion
Restricted Stock Unit
2015-02-12−2,246→ 4,495 totalExercise: $0.00Exp: 2017-02-12→ Common Stock (2,246 underlying) - Exercise/Conversion
Restricted Stock Unit
2015-02-12−1,355→ 5,315 totalExercise: $0.00Exp: 2017-02-12→ Common Stock (1,355 underlying) - Other
Restricted Stock Unit
2015-02-12−867→ 4,448 totalExercise: $0.00Exp: 2017-02-12→ Common Stock (867 underlying) - Exercise/Conversion
Common Stock
2015-02-12+2,246→ 8,474 total
Footnotes (3)
- [F1]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).
- [F2]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).
- [F3]This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.
Documents
Issuer
BIOGEN IDEC INC.
CIK 0000875045
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875045
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 8:26 PM ET
- Size
- 16.5 KB